MarketCapExport financials
PG&E Corporation (PCG)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
PG&E Corporation Financial Ratios 2025-2006 | PCG
Brief overview of PG&E Corporation's financial ratios
Ratios are assessed across five available annual reports in the 2020–2025 interval.
The latest available valuation ratios are P/E 13.11x (median 14.71x), EV/EBITDA 7.31x (median 11.44x), P/S 1.42x (median 1.41x). The multiple basket looks neutral against its history, differing from median levels by roughly -10.9%.
The inverse P/E implies an earnings yield of 7.6%. This is not a dividend yield, but current earnings relative to market price.
The latest available business-quality ratios are ROE 8.3%, ROA 1.9%, ROCE 3.8%. Business quality is below comfortable levels on current returns. Better margins or turnover are needed.
PEG is 2.6x. Price is well ahead of embedded growth, making market expectations demanding.
The cash conversion cycle is 32.8 days versus 37.4 days initially. Turnover changed little.
Overall picture
PG&E Corporation's market valuation is near its own historical norm, while quality ratios provide no extreme signal.
Annual Financial Ratios PG&E Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.1 | 13.7 | 14.8 | 17.7 | -248.1 | 14.7 | -1.0 | -1.0 | 12.9 | 21.5 | 29.9 | 19.0 | 22.5 | 21.7 | 18.9 | 14.0 | 11.4 | 10.4 | 17.1 | - | |
P/S |
1.4 | 1.4 | 1.4 | 1.5 | 1.1 | 0.3 | 0.5 | 0.4 | 1.3 | 1.7 | 1.6 | 1.6 | 1.2 | 1.2 | 1.1 | 1.1 | 1.0 | 1.0 | 1.3 | - |
EPS |
1.2 | 1.2 | 1.1 | 0.9 | -0.1 | -1.1 | -14.5 | -13.2 | 3.2 | 2.8 | 1.8 | 3.1 | 1.8 | 1.9 | 2.1 | 2.9 | 3.2 | 3.6 | 2.8 | - |
EV (Enterprise Value) |
34.7 B | 33.6 B | 32.7 B | 31.3 B | 21.5 B | 10.5 B | 86.1 B | 69.5 B | 69.6 B | 80.5 B | 73 B | 71.5 B | 59.3 B | 56.7 B | 53.1 B | 15.3 B | 13.4 B | 13.7 B | 16.8 B | -456 M |
EBITDA per Share |
2.16 | 2.08 | 1.29 | 0.92 | 0.949 | 4.14 | 8.66 | 9.88 | 11.3 | 9.88 | 8.51 | 10.4 | 8.65 | 9.35 | 10.4 | 6.04 | 6.25 | 6.33 | 6.02 | - |
EV/EBITDA |
7.3 | 7.5 | 12.2 | 17.0 | 11.4 | 2.0 | 1.7 | 5.4 | 6.9 | 9.8 | 10.6 | 8.8 | 8.6 | 7.8 | 7.1 | 6.6 | 5.8 | 6.1 | 8.0 | - |
PEG |
2.6 | -2.23 | -0.71 | -0.56 | 8.88 | 0.14 | 0.11 | 0.0 | 0.8 | 0.4 | -0.73 | 0.29 | -4.75 | -2.54 | -0.75 | - | - | - | - | - |
P/B |
0.3 | 0.3 | 0.3 | - | 0.2 | 0.3 | 1.5 | 0.6 | 1.1 | 1.7 | 1.6 | 1.7 | 1.3 | 1.4 | 1.3 | 0.3 | 0.3 | 0.3 | - | - |
P/CF |
4.1 | 4.3 | 7.0 | 8.6 | 9.7 | -0.3 | -5.3 | -4.0 | 64.0 | -23.3 | -18.7 | -23.8 | -10.5 | 69.7 | -54.2 | 4.9 | 4.6 | 5.0 | 6.7 | - |
ROE % |
8.31 | 8.33 | 9.01 | 7.86 | -0.42 | 1.96 | -148.79 | -54.04 | 8.64 | 7.84 | 5.36 | 9.21 | 5.77 | 6.35 | 7.09 | 9.87 | 11.81 | 14.27 | 11.43 | - |
ROA % |
1.91 | 1.88 | 1.79 | - | -0.09 | 0.42 | -8.97 | -8.88 | 2.44 | 2.05 | 1.40 | 2.41 | 1.49 | 1.58 | 1.72 | 2.42 | 2.84 | 3.27 | - | - |
ROCE % |
3.80 | 3.81 | 2.47 | 7.96 | 2.20 | 1.77 | 1.73 | 5.87 | 4.86 | 3.57 | 2.65 | 4.52 | 3.66 | 3.67 | 4.62 | 5.98 | 6.41 | 6.86 | 24.01 | - |
Current Ratio |
- | - | - | - | - | 63.2 | 1.3 | 0.2 | 0.9 | 0.8 | 0.9 | 1.1 | 0.8 | 0.8 | 0.8 | - | - | - | - | - |
DSO |
32.8 | 31.9 | 15.3 | 19.7 | 37.4 | - | 148.9 | 137.0 | 91.0 | 99.4 | 90.2 | 97.8 | 90.5 | 77.9 | 67.8 | 23.8 | 35.5 | 21.8 | - | - |
DIO |
- | - | - | - | - | - | 18.8 | 17.4 | 15.5 | 13.3 | 12.6 | 14.2 | 14.1 | 14.6 | 28.7 | - | - | - | - | - |
DPO |
- | - | - | - | - | 4.6 | 56.8 | 61.9 | 53.0 | 42.9 | 40.6 | 37.2 | 40.1 | 40.9 | 181.0 | - | - | - | - | - |
Operating Cycle |
32.8 | 31.9 | 15.3 | 19.7 | 37.4 | - | 167.7 | 154.4 | 106.5 | 112.7 | 102.9 | 112.0 | 104.6 | 92.5 | 96.5 | 23.8 | 35.5 | 21.9 | - | - |
Cash Conversion Cycle |
32.8 | 31.9 | 15.3 | 19.7 | 37.4 | -4.6 | 110.9 | 92.5 | 53.5 | 69.8 | 62.3 | 74.8 | 64.4 | 51.6 | -84.4 | 23.8 | 35.5 | 21.9 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios PG&E Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.39 | 0.37 | 0.24 | 0.28 | 0.27 | 0.24 | 0.34 | 0.16 | 0.2 | 0.29 | - | 0.23 | - | 0.24 | - | -0.55 | 0.2 | 0.06 | - | 0.04 | -3.73 | 0.7 | - | -3.06 | -4.83 | 0.25 | - | 1.09 | -1.91 | 0.86 | - | 1.07 | 0.79 | 1.13 | - | 0.77 | 0.41 | 0.22 | - | 0.63 | 0.84 | 0.06 | - | 1.72 | 0.57 | 0.49 | - | 0.36 | 0.74 | 0.55 | - | 0.84 | 0.56 | 0.56 | - | 0.5 | 0.91 | 0.5 | 0.66 | 0.88 | 0.69 | 0.84 | 1.03 |
EBITDA per Share |
0.67 | 0.55 | 0.5 | 0.56 | 0.48 | 0.53 | 0.6 | 0.19 | 0.25 | 0.32 | - | 0.37 | - | 0.27 | - | 0.15 | 0.32 | 0.15 | - | 0.2 | 0.53 | 1.24 | - | -4.35 | -6.88 | 0.36 | - | 1.35 | -2.84 | 1.16 | - | 1.73 | 1.44 | 1.71 | - | 1.28 | 0.81 | 0.19 | - | 1.12 | 1.43 | 0.15 | - | 2.26 | 1.11 | 1.05 | - | 0.65 | 1.44 | 1.16 | - | 1.43 | 1.1 | 1.18 | - | 1.01 | 1.73 | 1.22 | 1.29 | 1.86 | 1.67 | 1.64 | 1.78 |
ROE % |
9.15 | 8.64 | 7.98 | 9.08 | 8.46 | 8.03 | 8.49 | 7.70 | 7.88 | 8.36 | 5.91 | 0.66 | 0.43 | -0.63 | -2.83 | -2.42 | -6.55 | -6.61 | -7.18 | -38.64 | -88.68 | -76.67 | -78.45 | -73.96 | -50.25 | 2.90 | 0.25 | 3.13 | 0.78 | 11.54 | 8.02 | 10.20 | 8.50 | 6.98 | 3.96 | 5.83 | 6.10 | 5.14 | 4.52 | 9.69 | 9.54 | 8.56 | 8.35 | 9.49 | 6.64 | 6.61 | 5.15 | 7.93 | 8.61 | 8.10 | 6.42 | 8.09 | 8.34 | 8.18 | 6.37 | 8.74 | 10.16 | 9.65 | 11.14 | 12.72 | 2.52 | 3.16 | 3.94 |
ROA % |
2.11 | 1.92 | 1.71 | 1.88 | 1.70 | 1.60 | 1.68 | 1.50 | 1.67 | 0.28 | -0.20 | 0.20 | -0.19 | -0.07 | -0.53 | -0.44 | -1.40 | -1.42 | -1.54 | -3.44 | -6.52 | -4.35 | -4.73 | -3.99 | -3.37 | 0.20 | 0.04 | 0.85 | 0.72 | 2.85 | 2.27 | 2.84 | 2.33 | 1.89 | 1.04 | 1.53 | 1.60 | 1.35 | 1.19 | 2.54 | 2.50 | 2.24 | 2.19 | 2.48 | 1.73 | 1.71 | 1.33 | 2.02 | 2.18 | 2.03 | 1.60 | 2.01 | 2.05 | 2.00 | 1.55 | 2.13 | 2.48 | 2.34 | 2.69 | 3.04 | 0.60 | 0.75 | 0.93 |
ROCE % |
4.07 | 3.83 | 3.86 | 4.09 | 3.42 | 3.00 | 2.59 | 2.15 | 2.39 | 2.28 | 1.67 | 2.42 | 1.71 | 2.07 | 1.45 | 1.93 | 1.91 | 1.94 | 1.59 | -7.00 | -21.08 | -20.71 | -21.49 | -19.50 | -15.09 | 0.22 | -0.49 | 0.98 | 0.20 | 5.81 | 4.10 | 5.16 | 4.35 | 3.30 | 1.87 | 2.83 | 2.99 | 2.46 | 2.30 | 4.28 | 4.27 | 3.96 | 3.83 | 4.44 | 3.79 | 3.88 | 2.99 | 4.32 | 4.73 | 4.46 | 3.41 | 4.39 | 4.71 | 4.85 | 3.79 | 5.12 | 6.06 | 6.14 | 6.70 | 7.27 | 1.74 | 1.72 | 1.90 |
DSO |
28.3 | 31.9 | 32.2 | 33.8 | 32.9 | 31.6 | 33.8 | 33.2 | 40.3 | 18.9 | - | 23.1 | - | 34.8 | - | 31.1 | 32.8 | 36.0 | - | 35.2 | 37.9 | 33.6 | - | 26.5 | 29.8 | 27.7 | - | 23.9 | 24.7 | 26.9 | - | 25.1 | 26.7 | 26.7 | - | 23.8 | 27.4 | 27.1 | - | 22.2 | 23.9 | 24.2 | - | 17.7 | 22.2 | 24.1 | - | 23.9 | 26.4 | 25.2 | - | 21.5 | 23.8 | 24.2 | - | 23.4 | 24.6 | 25.1 | 23.8 | 33.5 | 41.2 | 43.6 | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | 23.1 | - | 34.8 | - | 31.1 | 32.8 | 36.0 | - | 35.2 | 37.9 | 33.6 | - | 26.5 | 29.8 | 27.7 | - | 23.9 | 24.7 | 26.9 | - | 25.1 | 26.7 | 26.7 | - | 23.8 | 27.4 | 27.1 | - | 22.2 | 23.9 | 24.2 | - | 17.7 | 22.2 | 24.1 | - | 23.9 | 26.4 | 25.2 | - | 21.5 | 23.8 | 24.2 | - | 23.4 | 24.6 | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | 23.1 | - | 34.8 | - | 31.1 | 32.8 | 36.0 | - | 35.2 | 37.9 | 33.6 | - | 26.5 | 29.8 | 27.7 | - | 23.9 | 24.7 | 26.9 | - | 25.1 | 26.7 | 26.7 | - | 23.8 | 27.4 | 27.1 | - | 22.2 | 23.9 | 24.2 | - | 17.7 | 22.2 | 24.1 | - | 23.9 | 26.4 | 25.2 | - | 21.5 | 23.8 | 24.2 | - | 23.4 | 24.6 | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company PG&E Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Russia
USA
